Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus helveticus Rosell-52 and Reduced Depression Symptoms

Research synthesisLow evidenceModerate effect4 studies · 4 beneficial · 0 neutral · 0 harmful

Across 4 studies, all reported beneficial effects of Lactobacillus helveticus Rosell-52 on depression symptoms, with effect sizes ranging from small to moderate. The most robust evidence comes from a 2025 meta-analysis of 7 RCTs showing a statistically significant moderate reduction in depressive symptoms (p = 0.03; SMD, -0.55; 95% CI, -1.04 to -0.06). Probiotics appear particularly beneficial in adults, though the evidence base is small and primarily derived from reviews and a single meta-analysis.

  • Studied populations: adults (general), adults with cancer

Caveats: Evidence base is small (only 4 studies) — conclusions should be considered preliminary. Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). The meta-analysis reported high heterogeneity (I² = 79%), suggesting inconsistent effects across trials. Most studies did not isolate the single strain's effect from multi-strain formulations, making it difficult to attribute benefits solely to Lactobacillus helveticus Rosell-52.

Generated May 12, 2026
4 of 4 papers
Back to top